Freitag, D. F., Butterworth, A. S., Willeit, P., Howson, J. M. M., Burgess, S., Kaptoge, S., . . . Lund University, P. a. a. o. s. r. e. (2015). Cardiometabolic effects of genetic upregulation of the interleukin 1 receptor antagonist. The Lancet Diabetes & Endocrinology, 3(4), 243. https://doi.org/10.1016/S2213-8587(15)00034-0
Chicago-referens (17:e uppl.)Freitag, Daniel F., et al. "Cardiometabolic Effects of Genetic Upregulation of the Interleukin 1 Receptor Antagonist." The Lancet Diabetes & Endocrinology 3, no. 4 (2015): 243. https://doi.org/10.1016/S2213-8587(15)00034-0.
MLA-referens (9:e uppl.)Freitag, Daniel F., et al. "Cardiometabolic Effects of Genetic Upregulation of the Interleukin 1 Receptor Antagonist." The Lancet Diabetes & Endocrinology, vol. 3, no. 4, 2015, p. 243, https://doi.org/10.1016/S2213-8587(15)00034-0.
